File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Non-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasone

TitleNon-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasone
Authors
KeywordsChronic subdural haematoma
Steroids
Treatment
Issue Date2005
Citation
British Journal of Neurosurgery, 2005, v. 19, n. 4, p. 327-333 How to Cite?
AbstractFrom a series of 112 cases (64 men and 48 women, aged 37-91 years) of chronic subdural haematoma (CSDH) in a 2-year period from January 1998 to December 1999, we have prospectively studied a group of 30 patients, who were managed non-operatively: 26 patients were treated with dexamethasone (Group 1) and four patients expectantly (Group 4). Nineteen patients (73%) from Group 1 were confused or had focal neurological deficits on admission. The mean maximum thickness of the CSDH was 12 mm. Only one of these cases (4%) required surgical drainage 6 weeks after steroid therapy. One patient died of an unrelated stroke (mortality = 4%). Two patients (8%) were left severely disabled. No significant complication from steroid therapy was documented. Out of the 85 surgically treated patients, 69 patients underwent surgical drainage in addition to steroid therapy (Group 2). Thirteen patients were treated with burr-hole drainage only (Group 3). The mean maximum thickness of the CSDH for these two groups were both 16 mm. Comparing with group 1, the redrainage rate of Group 2 [4% (3/69, p = 1)] and that of Group 3 [15% (2/13, p = 0.253)] were not significantly different. 50% of patients in Group 4 (2/4, p = 0.039) required delayed surgical drainage. The mortality rates of Groups 2, 3 and 4 were 3% (2/69, p = 1), 15% (2/13, p = 0.253) and 50% (2/4, p = 0.039), respectively. Our results suggest that steroid treatment in a selected group of patients is a good option, particularly in patients with co-morbidity. © The Neurosurgical Foundation.
Persistent Identifierhttp://hdl.handle.net/10722/325113
ISSN
2023 Impact Factor: 1.0
2023 SCImago Journal Rankings: 0.402
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSun, T. F.D.-
dc.contributor.authorBoet, R.-
dc.contributor.authorPoon, W. S.-
dc.date.accessioned2023-02-27T07:29:50Z-
dc.date.available2023-02-27T07:29:50Z-
dc.date.issued2005-
dc.identifier.citationBritish Journal of Neurosurgery, 2005, v. 19, n. 4, p. 327-333-
dc.identifier.issn0268-8697-
dc.identifier.urihttp://hdl.handle.net/10722/325113-
dc.description.abstractFrom a series of 112 cases (64 men and 48 women, aged 37-91 years) of chronic subdural haematoma (CSDH) in a 2-year period from January 1998 to December 1999, we have prospectively studied a group of 30 patients, who were managed non-operatively: 26 patients were treated with dexamethasone (Group 1) and four patients expectantly (Group 4). Nineteen patients (73%) from Group 1 were confused or had focal neurological deficits on admission. The mean maximum thickness of the CSDH was 12 mm. Only one of these cases (4%) required surgical drainage 6 weeks after steroid therapy. One patient died of an unrelated stroke (mortality = 4%). Two patients (8%) were left severely disabled. No significant complication from steroid therapy was documented. Out of the 85 surgically treated patients, 69 patients underwent surgical drainage in addition to steroid therapy (Group 2). Thirteen patients were treated with burr-hole drainage only (Group 3). The mean maximum thickness of the CSDH for these two groups were both 16 mm. Comparing with group 1, the redrainage rate of Group 2 [4% (3/69, p = 1)] and that of Group 3 [15% (2/13, p = 0.253)] were not significantly different. 50% of patients in Group 4 (2/4, p = 0.039) required delayed surgical drainage. The mortality rates of Groups 2, 3 and 4 were 3% (2/69, p = 1), 15% (2/13, p = 0.253) and 50% (2/4, p = 0.039), respectively. Our results suggest that steroid treatment in a selected group of patients is a good option, particularly in patients with co-morbidity. © The Neurosurgical Foundation.-
dc.languageeng-
dc.relation.ispartofBritish Journal of Neurosurgery-
dc.subjectChronic subdural haematoma-
dc.subjectSteroids-
dc.subjectTreatment-
dc.titleNon-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasone-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1080/02688690500305332-
dc.identifier.pmid16455539-
dc.identifier.scopuseid_2-s2.0-32344441753-
dc.identifier.volume19-
dc.identifier.issue4-
dc.identifier.spage327-
dc.identifier.epage333-
dc.identifier.eissn1360-046X-
dc.identifier.isiWOS:000234483700006-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats